SYNLAB AG
SYNLAB AG
Information on First Quotation
- Description:
- New Company (Regulated Market)
- Segment on First Quotation:
- Prime Standard
- Transaction Type:
- New Issue
- Supersector:
- Pharma & Healthcare
- Sector:
- Pharma & Healthcare
- Subsector:
- Health Care
- Country:
- Germany
- Symbol:
- SYAB
- First Trading Day (in current segment; s. CSV at "Download"):
- 30 Apr 2021
- ISIN:
- DE000A2TSL71
- Class:
- Bearer shares without par value
- Offering Period:
- 19 Apr 2021 - 27 Apr 2021
- Issuing Method:
- Bookbuilding Procedure
- Bookbuilding Range:
- € 18.00 - 23.00
- Subscription Price:
- € 18.00
- First Price:
- € 18.00
- Leading Underwriter:
- Goldman Sachs, J.P. Morgan
- Underwriter:
Joint Global Coordinators & Joint Bookrunners:
Goldman Sachs, J.P. Morgan
Joint Bookrunners:
BofA Securities, Deutsche Bank, Barclays, BNP PARIBAS, HSBC, Jefferies, UniCredit Bank AG
Co-Lead Managers:
Crédit Agricole CIB, Natixis
Independent advisor:
Lilja & Co.- Placement Volume excl. Greenshoe:
- € 671,799,996.00
- Placement Volume in Shares excl. Greenshoe:
- 37,322,222
- Placement Volume incl. Greenshoe:
- € 754,437,942.00
- Placement Volume of Executed Greenshoe:
- € 82,637,946.00
- Placement Volume of New Shares:
- 22,222,222
- Placement Volume of Existing Shares:
- 19,690,997
- Greenshoe in Shares:
- 5,600,000
- Greenshoe Executed in Shares:
- 4,590,997
- Priority Allocation:
None
- Allocation friends & family:
- 0.00 %
- Capital Stock / Shares on First Quotation:
- 222,222,222
- Total Market Cap on First Quotation:
- € 4,000,000,000.00
- Market Cap (Free Float) on First Quotation:
- € 1,412,000,000.00
- Free Float on First Quotation:
- 35.30 %
- Change First Price compared to Issuing Price:
- 0.00 %
- Further Information:
- Delisting 12/07/2024 (Takeover)
- The Offering comprises up to 22.2 million newly issued ordinary bearer shares from a capital increase as well as 27.5 million ordinary bearer shares from the Pre-IPO shareholders. Cinven, Novo Holdings and Ontario Teachers' Pension Plan Board (together the "Institutional Shareholders") can additionally place up to 12.4 million ordinary bearer shares as an upsize option, subject to market demand. J.P. Morgan as Joint Global Coordinators on the date of pricing. In addition, the Institutional Shareholders will grant a Greenshoe option over 9.3 million ordinary bearer shares to cover possible over-allotments.
- On 12 May 2021, the stabilization manager had partially exercised the greenshoe option granted by the selling shareholders in connection with over-allotments for 4,590,997 ordinary bearer shares with no-par value of Synlab AG at the offer price of EUR 18.00 per share.
Number of Shares in Lockup Period
| Months | Shares |
|---|---|
| 6 | 174,709,003 |
Shareholder Structure on First Quotation
| Name | Before IPO | After IPO |
|---|---|---|
| Cinven (Luxco 1) S.A. | 55.00 % | 37.90 % |
| Novo Nordisk Foundation | 21.30 % | 14.90 % |
| Ontario Teachers' Pension Plan Board | 10.50 % | 7.30 % |
| Dr. Bartl Wimmer | 6.10 % | 4.60 % |
| Free Float | 0.00 % | 35.30 % |